Evaluating the Role of Topical Therapies in the Management of Rosacea: Focus on Combination Sodium Sulfacetamide and Sulfur Formulations

Cutis

Volumn 73, Issue 1 SUPPL., 2004, Pages 29-33

  Del Rosso, James Q ^a,b,c,d,e,f  

^a UNIVERSITY OF NEVADA   (United States)

^b Collagenix Inc ^*  (United States)

^c Dermik Laboratories Inc   (United States)

^d Galderma Laboratories   (United States)

^e Dermatology Company   (France)

^f Stiefel Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVAR; CLENIA; DERMATOLOGICAL AGENT; DRUG VEHICLE; ISETHIONIC ACID; METRONIDAZOLE; NOVACET; PLEXION; ROSANIL; ROSULA; SULFACET R; SULFACETAMIDE; SULFUR;

ACNE; ACNE VULGARIS; BACTERIAL INFECTION; CLINICAL TRIAL; COMEDO; CONFERENCE PAPER; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; ERYTHEMA; HUMAN; NONHUMAN; PAPULE; ROSACEA; SEBORRHEIC DERMATITIS; SKIN INFLAMMATION;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS, LOCAL; DRUG COMBINATIONS; HUMANS; ROSACEA; SULFACETAMIDE; SULFUR;

EID: 0842265663     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. National Disease and Therapeutic Index [survey]. Philadelphia, Pa: IMS Health; October 2001.
2. Dahl MV. Pathogenesis of rosacea. Adv Dermatol. 2001;17:29-45.
3. Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med. 1997;90:144-150.
4. Millikan L. The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed. 2003;2:43-47.
5. Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol. 1994;130:359-362.
6. Miyachi Y. Pharmacologic modulation of neutrophil functions. Clin Dermatol. 2000;18:369-373.
7. Akamatsu H, Komura J, Asada Y, et al. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res. 1991;283:162-166.
8. Jain A, Sangal L, Basal E, et al. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol Online J. 2002;8:2.
9. Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies. Cutis. 2002;70:271-275.
10. Del Rosso JQ. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis. 2000;66:7-13.
11. Webster GF. Treatment of rosacea. Semin Cutan Med Surg. 2001;20:207-208.
12. Scheman AJ. Cosmetic intolerance: choosing products for sensitive skin. Cosmet Dermatol. July 1999;12:28-30.
13. Torok HM. Rosacea skin care. Cutis. 2000;66(suppl 4):14-16.
14. Bikowski J. The use of cleansers as therapeutic concomitants in various dermatologic disorders. Cutis. 2001;68(suppl 5):12-19.
15. Wortzman MS. Evaluation of mild skin cleansers. Dermatol Clin. 1991;9:35-44.
16. Ertel K. Modern skin cleansers. Dermatol Clin. 2000;18:561-575.
17. Rosanil [package insert]. Fort Worth, Tex: Galderma Laboratories; 2003.
18. Plexion [package insert]. Scottsdale, Ariz: Medicis Pharmaceuticals; 2003.
19. Clenia [package insert]. Minneapolis, Minn: Upsher-Smith Laboratories; 2003.
20. Olansky S. Old drug - in a new system - revisited. Cutis. 1977;19:852-854.
21. Duemling WW. Sodium sulfacetamide in topical therapy. AMA Arch Derm Syphilol. 1954;69:75-82.
22. Yontef R. Topical use of sodium sulfacetamide in selected dermatoses. J Med Soc N J. 1955;52:416-418.
23. Baker K. Synergistic acne therapy. Southwest Med. 1956;37:287-288.
24. Tarimci N, Sener S, Kilinc T. Topical sodium sulfacetamide/sulfur lotion [letter]. J Clin Pharm Ther. 1997;22:301.
25. Dosik JS. Efficacy and tolerability review of a sodium sulfacetamide 10% and sulfur 5% short contact therapy for the treatment of acne vulgaris. In: Abstracts of the American Academy of Dermatology 61st Annual Meeting; March 21-26, 2003; San Francisco, California. Abstract P48.
26. Mills OH, Kligman AM. Is sulphur helpful or harmful in acne vulgaris? Br J Dermatol. 1972;86:620-627.
27. Strauss JS, Goldman PH, Nacht S, et al. A reexamination of the potential comedogenicity of sulfur. Arch Dermatol. 1978;114:1340-1342.
28. Sauder DN, Miller R, Gratton D, et al. The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatol Treat. 1997;8:79-85.
29. Swinyer LJ. Evaluation of a novel sodium sulfacetamide 10% and sulfur 5% prescription cleanser for the treatment of rosacea. In: Abstracts of the American Academy of Dermatology 59th Annual Meeting; March 2-7, 2001; Washington, DC. Abstract P147.
30. Del Rosso JQ. Keeping it clean: therapeutic cleansers for acne, rosacea and seborrheic dermatitis. Skin Aging. 2003;11:82-88.